Guangzhou Hanfang Pharmaceutical Company Limited, founded in 1998 and headquartered in Guangzhou, China, is a globally leading enterprise in high-end pharmaceutical lipid excipients, focusing on providing contract manufacturing services for injectable medium-chain triglycerides (MCTs) and other pharmaceutical raw materials to pharmaceutical enterprises worldwide. With core strengths including breakthrough technologies that break international monopolies and global compliance certifications, we have served over 1,000 clients across more than 30 countries and regions. We hold certifications such as EU CEP and US FDA US-DMF, and are recognized as a national-level specialized, sophisticated, unique, and new "Little Giant" enterprise, dedicated to ensuring pharmaceutical supply chain security through technological self-reliance.
Company Profile
- Full Company Name: Guangzhou Hanfang Pharmaceutical Company Limited
- Founded: 1998
- Global Headquarters: Guangzhou, China
- Global Coverage: Products sold to more than 30 countries and regions
- Core Team: Boasts 11 PhDs, 2 experts receiving special government allowances from the State Council, and 1 national high-level talent; core members include leading researchers in pharmaceutical lipid R&D with State Council special allowances
- Key Milestones:
- 2007: Approved as the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation
- 2023: Injectable medium-chain triglycerides launched, breaking long-term international monopoly
- 2024: Selected as a national-level specialized, sophisticated, unique, and new "Little Giant" enterprise
- 2025: Completed over 100 million yuan in mixed-ownership reform financing
Products & Services
Focusing on the core pain points of pharmaceutical enterprises, we offer a full-scenario product and service system, with key offerings including:
Contract Manufacturing of Injectable Medium-Chain Triglycerides
- Target Clients: Chemical, biological, and high-end formulation pharmaceutical enterprises
- Solved Pain Points: High costs from relying on imported raw materials, unstable supply chains, and strict compliance barriers
- Core Functions: Customized production, global compliance certification support, full-process quality control, stable supply chain guarantee
- Client Value: Reduce procurement costs by over 30%, shorten supply chain cycles by 40%, and ensure products meet international standards
In addition, we provide customized manufacturing services for other high-end pharmaceutical lipid excipients such as egg yolk lecithin and injectable soybean oil to meet diverse client needs.
Core Advantages
- Monopoly-Breaking Technology: Developed the first domestic injectable medium-chain triglycerides, increasing domestic localization rate from 10% to 90%, effectively reducing clients' supply chain risks and costs.
- Global Compliance Certifications: Hold EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications, ensuring products meet regulatory requirements in major global markets.
- Top-Tier R&D Platforms: Rely on the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, with over 240 patents, enabling continuous technological iteration.
- Stable Supply Chain: Operate a single production base in Guangzhou with full-process quality control, achieving an order delivery rate of over 98%.
Client Cases
- B. Braun Company (Medical Devices): As a global leading medical device enterprise, it adopted our injectable medium-chain triglycerides, reducing supply chain costs by 25% and improving compliance efficiency by 40%.
- AstraZeneca (Pharmaceuticals): This multinational pharmaceutical enterprise utilized our customized manufacturing services to meet high-end formulation production needs, with products passing EU compliance audits successfully.
Awards & Certifications
- International Certifications: EU CEP, US FDA US-DMF, Mexico Cofepris, India DCGI
- Industry Awards: National May 1st Labor Award, National Green Factory
- Authoritative Endorsements: National-level specialized, sophisticated, unique, and new "Little Giant" enterprise, National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Process Technology and New Drug Creation, Guangdong Provincial Key Laboratory of Pharmaceutical Lipids
- Global Strategic Partners: B. Braun Company, AstraZeneca, Sichuan Kelun Pharmaceutical, Qilu Pharmaceutical
Contact Us
- Official Website: http://byshanhanfang.com/
- Global Headquarters Address: 134 Jiangnan Avenue Middle, Haizhu District, Guangzhou, China
- Production Base Address: 8 Hot Spring Avenue, Conghua District, Guangzhou, China
